RecruitingPhase 4NCT06922344
Comparison of Efficacy of Oral Fluconazole Versus Oral Itraconazole in the Treatment of Pityriasis Versicolor
Sponsor
Khyber Teaching Hospital
Enrollment
106 participants
Start Date
Mar 1, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
This study compares the efficacy of two drugs, namely flucanazole and itraconazole for the treatment of a common fungal infection of skin.
Eligibility
Min Age: 18 YearsMax Age: 50 Years
Inclusion Criteria1
- All cases of Pityriasis versicolor
Exclusion Criteria3
- Patients with history of chronic renal or liver disease, malignancy , or undergoing any kind of chemotherapy or radiotherapy or having cardiac conduction abnormalities.
- Patients who received any anti-fungal therapy in the last one month.
- Pregnant or lactating women.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGFluconazole
Oral fluconazole prescribed to group A
DRUGItraconazole
Oral itraconazole prescribed to Group B
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06922344